Areas of Expertise:

Owner of Bergeson & Campbell, P.C. (B&C®), Ms. Bergeson has earned an international reputation for her deep and expansive understanding of the Toxic Substances Control Act (TSCA), the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), European Union Registration, Evaluation, Authorization and Restriction of Chemicals (REACH), and especially how these regulatory programs pertain to nanotechnology, biotechnology, and other emerging transformative technologies. Her knowledge of and involvement in the policy process allows her to develop client-focused strategies whether advocating before Congress, the U.S. Environmental Protection Agency (EPA), the U.S. Food and Drug Administration (FDA), or other governance and standard-setting bodies.

Ms. Bergeson counsels corporations, trade associations, and business consortia on a wide range of issues pertaining to chemical hazard, exposure and risk assessment, risk communication, minimizing legal liability, and evolving regulatory and policy matters pertinent to products of conventional, biotechnology, biobased chemicals, nanotechnologies, and other emerging technologies, particularly with respect to TSCA, FIFRA, Food Quality Protection Act (FQPA), REACH, and Occupational Safety and Health Administration (OSHA) matters.

According to the 2012 Chambers USA Guide: "The universally highly regarded Lynn Bergeson of Bergeson & Campbell, P.C. has a solid reputation in chemical and pesticide regulatory work, with particular expertise in nanotechnology. Peers predict that she is set to become 'one of the most important lawyers in America.'"

Representative Engagements:
• Assists a global manufacturer of industrial and consumer products register and maintain chemical product approvals in all jurisdictions in which its products are marketed.
• Among the first U.S. law firms to assist several manufacturers of nanoscale chemical products obtain approval for their innovations under TSCA, and have devised and maintained product stewardship programs in multiple global jurisdictions to manage these nanoscale products effectively.
• Among the first law firms judicially to challenge a Significant New Use Rule (SNUR) issued under TSCA Section 5 to eliminate or lessen commercial restrictions placed on the manufacture, processing, and distribution of a new chemical substance.
• Assists several biobased chemical manufacturers address difficult TSCA nomenclature and chemical identity issues and devise and implement product stewardship protocols to manage these products with downstream stakeholder.